FDA approval marks first and only subcutaneous anti-PD-(L)1 cancer immunotherapy SAN DIEGO, Sept. 12, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc.…
SHERBROOKE, QC, Sept. 12, 2024 /CNW/ - The Honourable Marie-Claude Bibeau, Minister of National Revenue, on behalf of the Honourable François-Philippe…